BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12075596)

  • 1. Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma? View 1.
    Anton A
    Br J Ophthalmol; 2002 Jun; 86(6):692-3; discussion 695. PubMed ID: 12075596
    [No Abstract]   [Full Text] [Related]  

  • 2. Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma? View 2.
    Skuta GL
    Br J Ophthalmol; 2002 Jun; 86(6):693-4; discussion 695. PubMed ID: 12075597
    [No Abstract]   [Full Text] [Related]  

  • 3. Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma? The controversy.
    Goldberg I
    Br J Ophthalmol; 2002 Jun; 86(6):691-2. PubMed ID: 12034694
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of beta blockers in open angle glaucoma.
    Marmion VJ
    Indian J Ophthalmol; 1982 Jul; 30(4):229-31. PubMed ID: 6131867
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical beta-blockers are not associated with an increased risk of treatment for depression.
    Kaiserman I; Kaiserman N; Elhayany A; Vinker S
    Ophthalmology; 2006 Jul; 113(7):1077-80. PubMed ID: 16815397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative analysis of life quality in patients receiving beta-blockers and xalathane (latanoprost)].
    Tugushi OA; Shliapuzhnikova AV; Listopadova NA
    Vestn Oftalmol; 2005; 121(4):41-3. PubMed ID: 16223045
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of chronic open-angle glaucoma].
    Assouline M; Renard G
    Rev Prat; 1990 Jun; 40(16):1497-8. PubMed ID: 1972809
    [No Abstract]   [Full Text] [Related]  

  • 8. An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension.
    Stewart WC; Leech J; Sharpe ED; Kulze J; Ellyn J; Day DG
    Am J Manag Care; 2002 Aug; 8(10 Suppl):S240-8. PubMed ID: 12188166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic open-angle glaucoma].
    Béchetoille A; Denis P; Nordmann JP; Sellem E; Valtot F
    J Fr Ophtalmol; 1997; 20(2):166-8. PubMed ID: 9099276
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the additive effect of bunazosin on latanoprost in primary open-angle glaucoma.
    Maruyama K; Shirato S; Haneda M
    Jpn J Ophthalmol; 2005; 49(1):61-2. PubMed ID: 15692779
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic antihypertensive medication and incident open-angle glaucoma.
    Müskens RP; de Voogd S; Wolfs RC; Witteman JC; Hofman A; de Jong PT; Stricker BH; Jansonius NM
    Ophthalmology; 2007 Dec; 114(12):2221-6. PubMed ID: 17568677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating open-angle glaucoma.
    Long K; Long R
    Nurse Pract Forum; 1994 Dec; 5(4):205-6. PubMed ID: 7827534
    [No Abstract]   [Full Text] [Related]  

  • 14. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
    Shimmyo M
    Am J Ophthalmol; 2005 Jun; 139(6):1148; author reply 1148-9. PubMed ID: 15953471
    [No Abstract]   [Full Text] [Related]  

  • 15. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma.
    Konstas AG; Kozobolis VP; Tersis I; Leech J; Stewart WC
    Eye (Lond); 2003 Jan; 17(1):41-6. PubMed ID: 12579169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta-blockers in collyria and their secondary effects].
    Mihail S
    Oftalmologia; 1990; 34(2):81-4. PubMed ID: 1983167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Have the problems of beta blockers been overrated?
    Harv Heart Lett; 2000 Aug; 10(12):4-5. PubMed ID: 10927641
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use and hazards of beta blockers].
    Flammer J
    Ther Umsch; 1984 Apr; 41(4):251-4. PubMed ID: 6145231
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic β-Blockers Do Not Affect Glaucoma Eye Drop Effectiveness.
    Johnson TV; Jampel HD
    Ophthalmology; 2021 Feb; 128(2):326-328. PubMed ID: 32622847
    [No Abstract]   [Full Text] [Related]  

  • 20. [Analysis of the effectiveness of beta-blockers for intraocular pressure and visual field in primary open-angle glaucoma].
    Dobre X
    Oftalmologia; 2008; 52(4):95-9. PubMed ID: 19354170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.